Prestige Consumer Healthcare Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
6.9%projected annual EPS growth
Analyst Coverage
5analysts covering
FY Revenue (est.)
$1.3Bnext fiscal year
FY EPS (est.)
$4.59next fiscal year
Monitoring Framework
Key Performance Indicators
Organic Revenue Growth Annually-450.0%Target: 1% to 3%
Adjusted Free Cash Flow Annually246.4MTarget: 250000000 or more
Adjusted Diluted EPS Annually4.4Target: 4.42 to 4.51
Watch Items
- Clear Eyes Supply Chain RecoveryTrigger: Production output at Pillar5 facilityAction: Monitor high-speed line updates and inventory levels to meet robust consumer demand.
- Breathe Right Integration and LeverageTrigger: Secured leverage ratio exceeding 4.0x EBITDAAction: Track debt paydown progress and synergy realization from the newly completed $1.045 billion acquisition.
- LaCorium Health Acquisition ClosingTrigger: Closing of transaction in Q2 Fiscal 2027Action: Verify regulatory clearances and initial top-line contribution of the Australian therapeutic skin care brand.
Research as of 19 Jun 2026